ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis

M. Levy, G. B. Ferraro, M. Planoutene, L. Li, Y. Han, L. Varicchio, S. Fournier, X. An, S. J. Morris, M. Koehler, R. Hoffman, A. J. Fretland, A. Roulston, Y. Z. Ginzburg

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S100
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

Cite this